During the past decade, LKH Villach conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LKH Villach" #1 sponsor was "Landeskrankenanstalten-Betriebsgesellschaft" with 2 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LKH Villach" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "European Commission" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Barmherzige Brüder Vienna" with 1 trials as a collaborator and "Centre Hospitalier Régional de la Citadelle" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "LKH Villach" are "Breast Cancer" (2 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Coronary Artery Stenosis" (1 trials), "Covid19" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "LKH Villach" in a lesser frequency.

Most popular intervention types in "LKH Villach" are "Drug" (6 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "Carboplatin" (1 trials), "Cholecalciferol" (1 trials), "Farletuzumab" (1 trials) and "Farletuzumab-matched placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKH Villach" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "LKH Villach". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in LKH Villach, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LKH Villach, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".